Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 6, 2024Annals of Case ReportsOpen Access

Evidence That Circulating T Cells at Treatment Onset Predict Response to PD-1 Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

CSChristina SalamalikiEvangelismos HospitalFPFotini PouliasiELElias LiolisUniversity of Patras

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Salamaliki et al. (2024) studied this question.

synapsesocial.com/papers/68e6b6eab6db6435876389b4https://doi.org/10.29011/2574-7754.101788
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Improved Survival with Ipilimumab in Patients with Metastatic Melanoma2010 · 15,374 citations
  2. 2Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL2017 · 283 citations
  3. 3Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade2022 · 76 citations
  4. 4Endogenous IL-17 contributes to reduced tumor growth and metastasis2009 · 403 citations
  5. 5Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study2022 · 39 citations